Home > Drugs A – Z > Pralatrexate (Injection)

Pralatrexate (Injection)

Treats T-cell lymphoma.

What works?

Learn more about the effects of these drugs. The most reliable research is summed up for you in our featured article.

Pralatrexate injection is used to treat peripheral T-cell lymphoma (PTCL) in patients who have already been treated with other medicines that did not work well. Peripheral T-cell lymphoma is a rare type of cancer that affects certain white blood cells and causes enlarged and swollen lymph nodes in the neck, armpits, and groin. Pralatrexate belongs to the group of medicines called antineoplastics (Read more
Brand names include
Folotyn
Drug classes About this
Antineoplastic Agent

What works? Research summarized

Reviews in PubMed

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. [Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011]

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma. [Therapeutics and clinical risk management. 2011]

New drugs for the treatment of advanced-stage diffuse large cell lymphomas. [Seminars in hematology. 2006]

Summaries for consumers

Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®): Patient Version

Expert-reviewed information summary about the treatment of mycosis fungoides and the Sézary syndrome.

PubMed Health Blog...

read all...